Latest News & Features
Asia-Pacific
The Federal Court in Australia has ruled in Cancer Voices Australia v. Myriad Genetics that isolated genetic material is patentable in Australia. Karen Sinclair explains the relevant issues. 1 February 2013
Americas
The latest rulings in the controversial legal battle over breast cancer gene patents seem to have found two out of three issues in defendant Myriad Genetics’ favour, but legal counsel Ben Jackson isn’t too excited by the implications. 1 December 2012
Americas
The status of patentability for new dosage regimes in Mexico is unclear, but there have been some positive signs, says Pablo Fuentes. 1 May 2012
Americas
When introducing medicinal products to any market, the strength of the trademark is crucial. But the Mexican system requires getting trademark approval from two different authorities. 1 May 2012
Big Pharma
Brazil’s IP system has struggled to keep pace with its economic growth, but as Otto Licks and Marcela Trigo explain, there are some promising signs. 1 May 2012
Big Pharma
Russia’s life sciences industry is growing rapidly, say Vadim Chagin and Maria Nilova. 1 May 2012
Asia
For the first time in the history of the Indian patent system, a compulsory licence has been granted. Archana Shanker considers the implications. 1 May 2012
article
LSIPR talks to Matt McBride about how Science IP can help businesses ensure their patent plans get off to the best possible start. 1 May 2012
Americas
The system governing preliminary injunctions for pharmaceutical patent infringement should be revised to
stave off potential frivolous cases, say Hedwig Lindner and Manuel Morante. 1 May 2012
Biotechnology
The Supreme Court’s much-anticipated Prometheus decision has prompted strong reactions among IP practitioners, as MaryAnne Armstrong, PhD, explains. 1 January 2012